[1]
2024. A CASE REPORT OF POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME FOLLOWING RITUXIMAB THERAPY. Romanian Journal of Diabetes, Nutrition and Metabolic Diseases. 31, 1 (Apr. 2024), 673–677.